Characterization of etoposide-resistant choriocarcinoma cells and contribution of MAPK7 to etoposide resistance
BMC Cancer · 2026
DOI: 10.1186/s12885-026-16640-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Cancer, 2026. Verfasst von Yuko Yasui und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsuruma-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan. Hauptthemen laut MEDLINE: Etoposide, Drug Resistance, Neoplasm, Choriocarcinoma, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Gestational choriocarcinoma is an aggressive gynecologic malignancy that can occur with various pregnancy events. Although typically highly sensitive to combination chemotherapy, this malignancy, in a subset of patients, develops resistance to etoposide-containing regimens, leading to therapeutic failure. We aimed to elucidate the molecular mechanisms that confer resistance to etoposide, a central component of choriocarcinoma chemotherapy.
Methods
Etoposide-resistant JAR and JEG-3 choriocarcinoma cell lines were established by continuous stepwise exposure of parental cells to increasing concentrations of etoposide. Phenotypic comparisons with the parental cells were then performed. RNA sequencing and upstream regulator analyses were conducted to identify key regulatory molecules and signaling pathways associated with etoposide resistance. Candidate molecules were further evaluated by siRNA-mediated knockdown to assess their effects on etoposide sensitivity.
Results
Compared with their parental cells, etoposide-resistant choriocarcinoma cells demonstrated significantly reduced proliferation ( p < 0.001), migration ( p < 0.05), and invasion ( p < 0.01). RNA sequencing and pathway analyses revealed suppression of pathways related to cell cycle progression and DNA replication. In addition, upstream regulator analysis focusing on kinases suggested the involvement of MAPK-related molecules, including MAPK9, MAP2K5, and MAPK7. siRNA-mediated suppression of MAPK7 in resistant cells restored sensitivity to etoposide, suggesting a role for MAPK7 in the maintenance of etoposide resistance.
Conclusion
Our findings indicate that the MAPK signaling pathway, particularly MAPK7, contributes to etoposide resistance in choriocarcinoma, based on RNA sequencing and functional analyses of resistant cell models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsuruma-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan.
- Department of Obstetrics and Gynecology, Aichi Medical University School of Medicine, Nagakute, Japan.
- Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsuruma-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan. yoshida.kousuke@med.nagoya-u.ac.jp.
- Institute for Advanced Research, Nagoya University, Nagoya, Japan. yoshida.kousuke@med.nagoya-u.ac.jp.
- Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan.
- Department of Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan.
ORCID-Profile: Kosuke Yoshida
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yasui, Y., Yoshida, K., Nishiko, Y., Suzuki, H., Yamamoto, Y., Mogi, K., Yoshihara, M., Nagao, Y., Tamauchi, S., Yokoi, A., Yoshikawa, N., Nishino, K., Yamamoto, E., Niimi, K., & Kajiyama, H. (2026). Characterization of etoposide-resistant choriocarcinoma cells and contribution of MAPK7 to etoposide resistance. BMC Cancer. https://doi.org/10.1186/s12885-026-16640-9
Vancouver
Yasui Y, Yoshida K, Nishiko Y, Suzuki H, Yamamoto Y, Mogi K, et al. Characterization of etoposide-resistant choriocarcinoma cells and contribution of MAPK7 to etoposide resistance. BMC Cancer. 2026. doi:10.1186/s12885-026-16640-9
BibTeX
@article{Yasui2026,
author = {Yasui, Yuko and Yoshida, Kosuke and Nishiko, Yuki and Suzuki, Hironori and Yamamoto, Yusuke and Mogi, Kazumasa and Yoshihara, Masato and Nagao, Yukari and Tamauchi, Satoshi and Yokoi, Akira and Yoshikawa, Nobuhisa and Nishino, Kimihiro and Yamamoto, Eiko and Niimi, Kaoru and Kajiyama, Hiroaki},
title = {Characterization of etoposide-resistant choriocarcinoma cells and contribution of MAPK7 to etoposide resistance},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-16640-9}
}
EUVIMED